Our cutting-edge Native™ Antibody discovery, Hyperdoma™ and Phage Display platforms allow the production of the most comprehensive list of virology recombinant antibody products. Our antibody products range from research use only antibody, diagnostic antibody to therapeutic antibody. We also provide professional custom antibody discovery, engineering and manufacturing services, including featured phage display library construction, antibody humanization, chimerization, engineered antibody production (Fab, scFc, tribody, bispecific antibody, sdAb, minibody etc.), antibody labeling, hybridoma/s
Facing issue in account approval? email us at info@ipt.pw
Click to Ckeck Our - FREE SEO TOOLS
Our cutting-edge Native™ Antibody discovery, Hyperdoma™ and Phage Display platforms allow the production of the most comprehensive list of virology recombinant antibody products. Our antibody products range from research use only antibody, diagnostic antibody to therapeutic antibody. We also provide professional custom antibody discovery, engineering and manufacturing services, including featured phage display library construction, antibody humanization, chimerization, engineered antibody production (Fab, scFc, tribody, bispecific antibody, sdAb, minibody etc.), antibody labeling, hybridoma/s
Creative Biolabs is one of the few companies who can offer integrated drug discovery services for clients all over the world. Talented and well-trained scientists are working closely with each other to realize the goal of our customers. To discover and develop the qualified medicines of tomorrow, our scientists are concentrating on every important aspect of the industry, especially for the drug discovery pipeline. Our services range from target identification and validation, hit identification, hit to lead, lead optimization to the investigational new drug (IND), and are subdivided into numer
Creative Biolabs is one of the few companies who can offer integrated drug discovery services for clients all over the world. Talented and well-trained scientists are working closely with each other to realize the goal of our customers. To discover and develop the qualified medicines of tomorrow, our scientists are concentrating on every important aspect of the industry, especially for the drug discovery pipeline. Our services range from target identification and validation, hit identification, hit to lead, lead optimization to the investigational new drug (IND), and are subdivided into numer
Creative Biolabs provides high quality transcription-activator-like effector nuclease. Please contact us if you need more information.
Creative Biolabs provides high quality transcription-activator-like effector nuclease. Please contact us if you need more information.
The successful preparation of cadmium haptens is essential for preparing specific antibodies, which are promising analytical tools for rapid and sensitive determination of metal ions in the environment. Creative Biolabs is leading in the field of haptens design and synthesis; we can provide the best-fit cadmium haptens for our customers all over the world.
Creative Biolabs has an entrepreneurial team of highly-skilled and qualified experts in hapten design and small-molecule antibody development. The members have originated from a rich academic research background, bringing their experience into translation. We are very proud of providing high-quality, omnidirectional compound-specific hapten-based services targeting β-agonists to our valued clients to remove the difficulties of your projects.
The development of cancer immunotherapies relies on an accurate understanding of the cellular composition and complex interactions between cells in the tumor microenvironment. To discover the secrets inside individual cells, Creative Biolabs developed a comprehensive suite of single cell omics solutions for your immuno oncology programs. We are dedicated to assisting you with exploring insights for novel cancer immunotherapies.
Tumor microenvironment (TME) is a multifaceted ecosystem with profound cellular heterogeneity, dynamics, and complex intercellular crosstalk. Although the acquisition of oncogene function and the loss of anti-oncogene function are the driving forces of tumorigenesis and development, TME, including extracellular matrix, peripheral matrix, signal molecules, infiltrating immune cells and other cell groups, is also considered to be the key to tumorigenesis and metastasis. Therefore, factors involved in the interaction of TME may provide new targets for diagnostic development and therapeutic inter
Single domain antibodies (sdAbs, or VHH) are the smallest antigen-binding units of antibodies, comprising either one variable domain or one engineered constant domain that solely facilitates target binding. They are popular as a novel class of proprietary therapeutic proteins containing unique structural and functional properties. At Creative Biolabs, we offer one-stop solutions for sdAb development and characterization to promote the identification of novel therapeutic sdAbs to meet your specific project demands.
Recombinant F7 Protein aa 61-212 His Human origin
Recombinant GDI1 Protein aa 1-447 His Human origin
Ligand Design for Retinoic Acid Receptors (RAR)-targeting PROTAC
X-protein ligands
In the years spent in the research of phage-based applications, Creative Biolabs has acquired solid know-how in the field of in phage-based tools for pathogen detection. Our skilled experts have been established an unparalleled unmodified bacteriophages platform which includes phage typing, phage amplification, phage-mediated electrochemical-based methods, surfaces plasmon resonance-based sensor, and adenylate kinase techniques. These techniques are optimal for detection of interactions between phage and host bacteria.
Molecular cloning techniques makes it possible to engineer phage to carry a specific reporter gene, which provides an efficient alternative to native, unaltered phage particles for bacterial detection. Creative Biolabs is a biotechnology company who has rich experience in providing high-quality service in report phage engineering. We offer one-stop solutions to support you in all aspects of your report phage development.
Creative Biolabs is a forward-looking company as well as a leading customer service provider in the field of IgA antibody development. Our scientists specialized in therapeutic antibody studies will work with you to develop the most appropriate strategy that will offer the most meaningful data for your research. We have experienced experts and advanced platforms that are able to provide excellent discovery services on therapeutic IgA antibodies.
Since the commercial development of therapeutic monoclonal antibodies commenced in the early 1980s, the monoclonal antibodies have grown to become the most successful class of biotech drugs for the diagnosis and treatment against various diseases and infections. Besides the traditional IgG antibody, Creative Biolabs can help to develop Non-IgG therapeutic antibodies for our customers all over the world.
Our cutting-edge hybridoma development and phage display platforms allow the production of the most comprehensive list of recombinant antibody products and extensive service portfolio at the most competitive price. Our products range from antibody / peptide libraries, Biosimilar cell lines, Chimeric antigen receptor (CAR) products, antibody-drug conjugates (ADCs) to engineered antibodies such as therapeutic antibodies, single-domain antibodies, bispecific antibodies and intrabodies. We also provide professional custom antibody discovery and engineering services, featuring phage display librar